LOW FLAT RATE AUST-WIDE $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

$190.95

Loose-leaf

Not in-store but you can order this
How long will it take?

QTY:

English
John Wiley & Sons Inc
17 July 2015
This text is an unbound, three hole punched version. Access to WileyPLUS sold separately.

Economics of Strategy, Binder Ready Version focuses on the key economic concepts students must master in order to develop a sound business strategy. Ideal for undergraduate managerial economics and business strategy courses, Economics of Strategy offers a careful yet accessible translation of advanced economic concepts to practical problems facing business managers. Armed with general principles, today's students--tomorrows future managers--will be prepared to adjust their firms business strategies to the demands of the ever-changing environment. 
By:   , , ,
Imprint:   John Wiley & Sons Inc
Country of Publication:   United States
Edition:   7th Revised edition
Dimensions:   Height: 252mm,  Width: 198mm,  Spine: 20mm
Weight:   953g
ISBN:   9781119042310
ISBN 10:   1119042313
Pages:   544
Publication Date:  
Audience:   College/higher education ,  Primary
Replaced By:   9781394278930
Format:   Loose-leaf
Publisher's Status:   Active

David Dranove is the Walter McNerney Distinguished Professor of Health Industry Management at Northwestern University's Kellogg School of Management, where he is also Professor of Strategy. He was previously Director of the Health Enterprise Management program. He has a PhD in Economics from Stanford University. Professor Dranove's research focuses on problems in industrial organization and business strategy with an emphasis on the health care industry. He has published nearly 100 research articles and book chapters and written five books, including The Economic Evolution of American Healthcare and Code Red. His textbook, The Economics of Strategy, is used by leading business schools around the world. Professor Dranove regularly consults with leading healthcare organizations in the public and private sector and has served on the Executive Committee and Board of Directors of the Health Care Cost Institute. He has also served as an economics expert in several high profile healthcare antitrust cases.

See Also